Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acasti Pharma Inc (NASDAQ:ACST)

1.58
Delayed Data
As of Feb 05
 +0.0799 / +5.33%
Today’s Change
1.34
Today|||52-Week Range
6.20
-38.04%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$16.8M

Company Description

Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of proprietary active pharmaceutical ingredients for the management of cardio metabolic disorders, from prevention to treatment and through a novel superior approach to lipid regulation. The company is advancing its portfolio of bioactive ingredients, by purifying and concentrating krill-oil extracts through innovative technology, to produce products targeting the prescription drug and medical food markets. Acasti Pharma was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.

Contact Information

Acasti Pharma, Inc.
545 Promenade du Centropolis
Laval Quă©bec H7T 0A3
P:(450) 686-4555
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Pierre LemieuxChief Operating Officer
Mario ParadisChief Financial Officer
Farhad AmiriDirector-Research & Development
Laurent HarveyVice President-Clinical & Non-Clinical Affairs
Fotini SampalisChief Global Strategy Officer